FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * RUNKEL JOHN F JR   2. Issuer Name and Ticker or Trading Symbol VISX INC [EYE] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Senior VP, Bus. Dev. & GC (Last) (First) (Middle) 3400 CENTRAL EXPRESSWAY 3. Date of Earliest Transaction (Month/Day/Year) 05/27/2005 (Street) SANTA CLARA, CA 95051 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 05/27/2005   D   3,595 D (1) 0 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Underlying Securities (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$ 13.75	05/27/2005		D			3,674	(2)	01/29/2011	Common Stock	3,674	(2)	0	D
Stock Option (Right to Buy)	$ 13.75	05/27/2005		D			2,357	(3)	01/29/2011	Common Stock	2,357	(3)	0	D
Stock Option (Right to Buy)	$ 15.14	05/27/2005		D			6,719	(4)	02/12/2012	Common Stock	6,719	(4)	0	D
Stock Option (Right to Buy)	$ 15.14	05/27/2005		D			19,312	(5)	02/12/2012	Common Stock	19,312	(5)	0	D
Stock Option (Right to Buy)	$ 8.03	05/27/2005		D			11,720	(6)	03/03/2013	Common Stock	11,720	(6)	0	D
Stock Option (Right to Buy)	$ 8.03	05/27/2005		D			11,718	(7)	03/03/2013	Common Stock	11,718	(7)	0	D
Stock Option (Right to Buy)	$ 19.73	05/27/2005		D			5,970	(8)	02/11/2014	Common Stock	5,970	(8)	0	D
Stock Option (Right to Buy)	$ 19.73	05/27/2005		D			31,530	(9)	02/11/2014	Common Stock	31,530	(9)	0	D
Stock Option (Right to Buy)	$ 19.85	05/27/2005		D			3,484	(10)	08/19/2014	Common Stock	3,484	(10)	0	D
Stock Option (Right to Buy)	$ 19.85	05/27/2005		D			31,516	(11)	08/16/2014	Common Stock	31,516	(11)	0	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
RUNKEL JOHN F JR 3400 CENTRAL EXPRESSWAY SANTA CLARA, CA 95051			Senior VP, Bus. Dev. & GC

Signatures

John F. Runkel, Jr.		06/01/2005
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Disposed of pursuant to merger agreement between issuer and Advanced Medical Optics, Inc. in exchange for 1,984 shares of Advanced Medical Optics, Inc. common stock on the effective date of the merger.
(2)	This option, which provided for vesting at 25% of the shares subject to the option vest upon the first anniversary of the grant and 1/48 of the shares subject to the option vest at the end of each full month for 36 months following the initial grant date of January 29, 2001, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 2,359 shares of Advanced Medical Optics, Inc. common stock for $21.42 per share.
(3)	This option, which provided for vesting at 25% of the shares subject to the option vest upon the first anniversary of the grant and 1/48 of the shares subject to the option vest at the end of each full month for 36 months following the initial grant date of January 29, 2001, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 1,513 shares of Advanced Medical Optics, Inc. common stock for $21.43 per share.
(4)	This option, which provided for vesting at 25% of the shares subject to the option vest upon the first anniversary of the grant and 1/48 of the shares subject to the option vest at the end of each full month for 36 months following the initial grant date of February 12, 2002, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 4,315 shares of Advanced Medical Optics, Inc. common stock for $23.58 per share.
(5)	This option, which provided for vesting at 25% of the shares subject to the option vest upon the first anniversary of the grant and 1/48 of the shares subject to the option vest at the end of each full month for 36 months following the initial grant date of February 12, 2002, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 12,403 shares of Advanced Medical Optics, Inc. common stock for $23.58 per share.
(6)	This option, which provided for vesting at 25% of the shares subject to the option vest upon the first anniversary of the grant and 1/48 of the shares subject to the option vest at the end of each full month for 36 months following the initial grant date of March 3, 2003, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 7,527 shares of Advanced Medical Optics, Inc. common stock for $12.51 per share.
(7)	This option, which provided for vesting at 25% of the shares subject to the option vest upon the first anniversary of the grant and 1/48 of the shares subject to the option vest at the end of each full month for 36 months following the initial grant date of March 3, 2003, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 7,525 shares of Advanced Medical Optics, Inc. common stock for $12.51 per share.
(8)	This option, which provided for vesting at 25% of the shares subject to the option vest upon the first anniversary of the grant and 1/48 of the shares subject to the option vest at the end of each full month for 36 months following the initial grant date of February 11, 2004, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 3,834 shares of Advanced Medical Optics, Inc. common stock for $30.73 per share.
(9)	This option, which provided for vesting at 25% of the shares subject to the option vest upon the first anniversary of the grant and 1/48 of the shares subject to the option vest at the end of each full month for 36 months following the initial grant date of February 11, 2004, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 20,250 shares of Advanced Medical Optics, Inc. common stock for $30.73 per share.
(10)	This option, which provided for vesting at 25% of the shares subject to the option vest upon the first anniversary of the grant and 1/48 of the shares subject to the option vest at the end of each full month for 36 months following the initial grant date of August 19, 2004, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 2,237 shares of Advanced Medical Optics, Inc. common stock for $30.92 per share.
(11)	This option, which provided for vesting at 25% of the shares subject to the option vest upon the first anniversary of the grant and 1/48 of the shares subject to the option vest at the end of each full month for 36 months following the initial grant date of August 19, 2004, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 20,241 shares of Advanced Medical Optics, Inc. common stock for $30.91 per share.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.